| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $2.5B | $2.3B | $2.3B | $2.4B | $2.8B | $1.4B | $2.5B | $2.2B |
| EPS (Basic) | $3.56 | $3.16 | $3.23 | $3.38 | $3.78 | $1.84 | $3.38 | $3.11 |
| EPS (Diluted) | $3.53 | $3.14 | $3.22 | $3.35 | $3.73 | $1.83 | $3.33 | $3.06 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $214.4B | $212.9B | $214.6B | $207.5B | $211.1B | $204.7B | $169.4B | $146.1B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Total Liabilities | $192.7B | $193.3B | $195.4B | $190.1B | $188.9B | $181.6B | $148.2B | $129.8B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $21.7B | $19.6B | $19.2B | — | — | — | $21.2B | $16.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $4.5B | $2.8B | $4.5B | $6.4B | $2.7B | $0.4B | $1.8B | — |
| Investing Cash Flow | $-1.8B | $1.0B | $-9.5B | $-4.9B | $-8.0B | $-31.9B | $-0.8B | — |
| Capital Expenditures | $0.6B | $0.4B | $0.5B | $0.3B | $0.3B | $0.3B | $0.2B | $0.2B |
| Financing Cash Flow | $-2.2B | $-4.0B | $4.7B | $-1.1B | $5.1B | $31.4B | $-0.4B | — |